Bothell, WA, United States of America

Carol J Raport

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carol J Raport

Introduction

Carol J Raport is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antikine antibodies. With a total of 8 patents to his name, Raport's work has had a considerable impact on medical research and therapeutic applications.

Latest Patents

One of Raport's latest patents involves antikine antibodies that bind to multiple CC chemokines. These antibodies can bind to two, three, four, five, or more CC chemokines, including RANTES/CCL5, MIP-1α/CCL3, MIP-1β/CCL4, and MCP-1/CCL2. The patent also discloses methods for affinity maturation and humanization of these antibodies, as well as the production of hybridoma cell lines that produce antikine antibodies through sequential immunization.

Career Highlights

Throughout his career, Raport has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Icos Corporation and Vlst Corporation. His work in these organizations has contributed to advancements in therapeutic antibody development and other innovative biotechnological solutions.

Collaborations

Raport has collaborated with various professionals in his field, including Patrick W Gray and Vicki Louise Schweickart. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Carol J Raport's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic strategies and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…